Graphite Bio, Inc.

NASDAQ:GRPH

3.18 (USD) • At close March 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 010.236000000000000000
Cost of Revenue 00.1420.82.0982.222.2222.1682.064000000000
Gross Profit 010.094-0.8-2.098-2.22-2.222-2.168-2.064000000000
Gross Profit Ratio 00.986000000000000000
Reseach & Development Expenses 10.5370.0012.38413.50816.24418.46218.30217.77718.24611.2058.68312.6675.3776.392.310.4230
General & Administrative Expenses 014.60111.2947.4557.6238.2897.8528.9997.7127.7365.9194.8663.9911.9331.4540.8690.121
Selling & Marketing Expenses 0-0.142000000000000000
SG&A 5.55114.45911.2947.4557.6238.2897.8528.9997.7127.7365.9194.8663.9911.9331.4540.8690.121
Other Expenses 00.07511.34937.1962.583000.840.1230.010.010.004-10.341-55.2130.3800
Operating Expenses 16.08814.4625.02720.96323.86726.75126.15426.77625.95818.94114.60217.5339.3688.3233.7641.2920.121
Operating Income -16.088-14.602-25.027-58.159-26.45-26.751-26.154-26.776-25.958-18.941-14.602-17.533-9.368-8.323-3.764-1.292-0.121
Operating Income Ratio 0-1.427000000000000000
Total Other Income Expenses Net -0.56-8.3162.5422.8452.5162.1521.4720.840.1230.0090.010.004-10.341-55.2130.38-0.02-0.02
Income Before Tax -16.648-22.918-22.485-55.314-23.934-24.599-24.682-25.936-25.835-18.931-14.592-17.529-19.709-63.536-3.384-1.312-0.141
Income Before Tax Ratio 0-2.239000000000000000
Income Tax Expense 0-31.073-0.76234.351-2.516-2.152-1.472-0.84-0.123-0.320.010.004-10.341-55.2130.3800
Net Income -16.648-22.918-22.485-55.314-21.418-22.447-23.21-25.096-25.712-18.931-14.592-17.529-19.709-63.536-3.384-1.312-0.141
Net Income Ratio 0-2.239000000000000000
EPS -3.53-2.77-2.75-6.82-2.68-2.82-2.94-3.22-3.33-2.48-1.94-3.45-2.53-13.01-0.69-0.27-0.029
EPS Diluted -3.53-2.77-2.75-6.82-2.68-2.82-2.94-3.22-3.33-2.48-1.94-3.45-2.53-13.01-0.69-0.27-0.029
EBITDA -16.088-14.46-1.56717.082-20.559-26.069-25.502-26.198-25.518-18.931-14.394-17.413-9.278-8.247-3.34-1.291-0.121
EBITDA Ratio 0-1.413000000000000000